Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Privitera

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Annals of Neurology|August 9, 2011
Is antiepileptic drug generic substitution always safe? Slow progress toward definitive answersMichael Privitera
The Lancet. Neurology|March 15, 2016
Michael PriviteraMichael Privitera
Epilepsy Research|June 10, 2017
Generic antiepileptic drug equivalence: The journey from anecdotes to evidenceMichael Privitera
Epilepsy Research|December 27, 2005
Large clinical trials in epilepsy: funding by the NIH versus pharmaceutical industryMichael Privitera
Epilepsy & Behavior : E&B|September 2, 2014
Progress in solving the stress-seizure conundrumMichael Privitera
The American Journal of Managed Care|July 19, 2011
Current challenges in the management of epilepsyMichael Privitera
Neurology. Clinical Practice|August 6, 2013
Generic substitution of antiepileptic drugs: What's a clinician to do?Michael Privitera
Epilepsy Currents|December 12, 2017
Epilepsy Treatment: A Futurist ViewMichael Privitera
Archives of Neurology|October 13, 2004
Levetiracetam induces a rapid and sustained reduction of generalized spike-wave and clinical absenceJennifer Cavitt, Michael Privitera
Neurology|August 9, 2006
How skeptical should we be about industry-sponsored studies?David Chadwick, Michael Privitera
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Annals of Neurology|August 9, 2011
Is antiepileptic drug generic substitution always safe? Slow progress toward definitive answersMichael Privitera
The Lancet. Neurology|March 15, 2016
Michael PriviteraMichael Privitera
Epilepsy Research|June 10, 2017
Generic antiepileptic drug equivalence: The journey from anecdotes to evidenceMichael Privitera
Epilepsy Research|December 27, 2005
Large clinical trials in epilepsy: funding by the NIH versus pharmaceutical industryMichael Privitera
Epilepsy & Behavior : E&B|September 2, 2014
Progress in solving the stress-seizure conundrumMichael Privitera
The American Journal of Managed Care|July 19, 2011
Current challenges in the management of epilepsyMichael Privitera
Neurology. Clinical Practice|August 6, 2013
Generic substitution of antiepileptic drugs: What's a clinician to do?Michael Privitera
Epilepsy Currents|December 12, 2017
Epilepsy Treatment: A Futurist ViewMichael Privitera
Archives of Neurology|October 13, 2004
Levetiracetam induces a rapid and sustained reduction of generalized spike-wave and clinical absenceJennifer Cavitt, Michael Privitera
Neurology|August 9, 2006
How skeptical should we be about industry-sponsored studies?David Chadwick, Michael Privitera
Pageof 7